Cryptic deletion involving the ATM locus at 11q22.3∼q23.1 in B-cell chronic lymphocytic leukemia and related disorders
- 1 July 2004
- journal article
- research article
- Published by Elsevier in Cancer Genetics and Cytogenetics
- Vol. 152 (1), 72-76
- https://doi.org/10.1016/j.cancergencyto.2003.10.010
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profileBlood, 2003
- V H mutation status, CD38 expression level, genomic aberrations, and survival in chronic lymphocytic leukemiaBlood, 2002
- CD38 expression and secondary 17p deletion are important prognostic factors in chronic lymphocytic leukaemiaBritish Journal of Haematology, 2002
- CD38 expression as an important prognostic factor in B-cell chronic lymphocytic leukemiaBlood, 2001
- Genomic Aberrations and Survival in Chronic Lymphocytic LeukemiaNew England Journal of Medicine, 2000
- Frequent deletions at 11q23 and 13q14 in B cell prolymphocytic leukemia (B-PLL)Leukemia, 2000
- Molecular characterization of deletion at 11q22.1‐23.3 in mantle cell lymphomaBritish Journal of Haematology, 1999
- Molecular cytogenetic delineation of a novel critical genomic region in chromosome bands 11q22.3-923.1 in lymphoproliferative disorders.Proceedings of the National Academy of Sciences, 1996
- Chronic Lymphocytic LeukemiaNew England Journal of Medicine, 1995
- 5 Cytogenetics in CLL and related disordersBailliere's Clinical Haematology, 1993